Pharmacogenomic characterization of gemcitabine response – a framework for data integration to enable personalized medicine

Biomarkers identified in this integrative analysis may contribute insights into gemcitabine response variability. As genotype data become more readily available, similar studies can be conducted to gain insights into drug response mechanisms and to facilitate clinical trial design and regulatory reviews.